Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
Clinical trial NCT03879629 · TERMINATED
Trial details
- NCT number
- NCT03879629
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-21
- Primary completion
- 2026-02-28
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.